International Collaborative Research Strategy for Alzheimer's Disease

The International Collaborative Research Strategy for Alzheimer's Disease, the first of CIHR's Roadmap Signature Initiatives, is led by the CIHR Institute of Aging and co-led by the Institute of Neurosciences, Mental Health and Addiction.

The goals of this Strategy are:

• Primary Prevention – Prevent the disease from occurring through the identification of the mechanisms and/or conditions responsible for the neurodegenerative processes that lead to Alzheimer's disease and related dementias.
• Secondary Prevention – Delaying/slowing the clinical progression of an already developing disease though better understanding of the mechanisms, diagnosis and early intervention.
• Quality of life – Improve the quality of life of those living with the disease or who support those having the disease as well as to improve access to quality care and enabling the healthcare system to deal more efficiently with the rising number of individuals with dementia.

This initiative will help provide Canadians with rapid access to the latest preventive, diagnostic and treatment approaches to Alzheimer's disease and related dementias.